Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model

Japanese Journal of Ophthalmology

Volumn 54, Issue 5, 2010, Pages 481-485

  Kobayakawa, Shinichiro ^a   Hiratsuka, Yoshimune ^b   Watabe, Yasuo ^b   Murakami, Akira ^b   Tochikubo, Tetsuo ^a  

^a TOHO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

endothelium; gatifloxacin; gentamicin; intracameral; moxifloxacin

Indexed keywords

GATIFLOXACIN; GENTAMICIN; MOXIFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA THICKNESS; DRUG SAFETY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; ENDOTHELIUM, CORNEAL; FLUOROQUINOLONES; GENTAMICINS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; QUINOLINES; RABBITS;

EID: 78649311747     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0838-5     Document Type: Article

References (28)

1. Endophthalmitis Study Group, European Society of CataractRefractive Surgeons. 2007 Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors J Cataract Refract Surg 33 978 988 10.1016/j.jcrs.2007.02.032
2. G. Wejde P. Montan M. Lundström U. Stenevi W. Thorburn 2005 Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001 Acta Ophthalmol Scand 83 7 10 10.1111/j.1600-0420.2005.00377.x 15715550
3. M. Garat C.L. Moser C. Alonso-Tarrés M. Martín-Baranera A. Alberdi 2005 Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study J Cataract Refract Surg 31 2230 2234 10.1016/j.jcrs.2005.08.053 16412945
4. D.V. Seal P. Barry G. Gettinby, et al. 2006 ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study J Cataract Refract Surg 32 396 406 10.1016/j.jcrs.2006.02.014 16631046
5. P. Barry D.V. Seal G. Gettinby F. Lees M. Peterson C.W. Revie ESCRS Endophthalmitis Study Group 2006 ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study J Cataract Refract Surg 32 407 410 10.1016/j.jcrs.2006.02.021 16631047
6. P. Romero I. Méndez M. Salvat J. Fernández M. Almena 2006 Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery J Cataract Refract Surg 32 438 441 10.1016/j.jcrs.2005.12.135 16631053
7. G.S. Ang C.W. Barras 2006 Prophylaxis against infection in cataract surgery: a survey of routine practice Eur J Ophthalmol 16 394 400 1:STN:280:DC%2BD28zks1Gkug%3D%3D 16761240
8. P. Gordon-Bennett A. Karas D. Flanagan C. Stephenson M. Hingorani 2008 A survey of measures used for the prevention of postoperative endophthalmitis after cataract surgery in the United Kingdom Eye 22 620 627 1:STN:280: DC%2BD1czhsFKmtw%3D%3D 10.1038/sj.eye.6702675 17173008
9. M. Lundström G. Wejde U. Stenevi, et al. 2007 Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location Ophthalmology 114 866 870 10.1016/j.ophtha.2006.11.025 17324467
10. E. Yoeruek M.S. Spitzer O. Saygili, et al. 2008 Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use J Cataract Refract Surg 34 2139 2145 10.1016/j.jcrs.2008. 08.022 19027573
11. S.S. Lane R.H. Osher S. Masket S. Belani 2008 Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery J Cataract Refract Surg 34 1451 1459 10.1016/j.jcrs.2008.05.034 18721703
12. S.Y. Kim Y.H. Park Y.C. Lee 2008 Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells Clin Experiment Ophthalmol 36 367 370 10.1111/j.1442-9071.2008.01771.x 18700925
13. T.P. O'Brien S.A. Arshinoff F.S. Mah 2007 Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin J Cataract Refract Surg 33 1790 1800 10.1016/j.jcrs.2007.06.026 17889778
14. C.R. Espiritu V.L. Caparas J.G. Bolinao 2007 Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients J Cataract Refract Surg 33 63 68 10.1016/j.jcrs.2006.09.019 17189795
15. R.P. Kowalski E.G. Romanowski F.S. Mah K.A. Yates Y.J. Gordon 2005 Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model Am J Ophthalmol 140 497 504 1:CAS:528:DC%2BD2MXpslarsLg%3D 16083841
16. P.G. Montan G. Wejde H. Setterquist M. Rylander C. Zetterström 2002 Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery J Cataract Refract Surg 28 982 987 10.1016/S0886-3350(01)01270- 6 12036640
17. C.H. Chang C.P. Lin H.Z. Wang 1995 Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture Cornea 14 71 76 1:STN:280:DyaK2M3ivVehtw%3D%3D 10.1097/00003226-199501000-00012 7712740
18. M.K. Jensen R.G. Fiscella M. Moshirfar B. Mooney 2008 Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years J Cataract Refract Surg 34 1460 1467 10.1016/j.jcrs.2008.05.045 18721704
19. J.P. McCulley D. Caudle J.D. Aronowicz W.E. Shine 2006 Fourth-generation fluoroquinolone penetration into the aqueous humor in humans Ophthalmology 113 955 959 1:STN:280:DC%2BD28zjtFykuw%3D%3D 10.1016/j.ophtha.2006.01.061 16603244
20. J.C. Pong W.W. Tang J.S. Lai 2008 Toxic endothelial cell destruction syndrome after intraocular lens repositioning with intracameral epinephrine J Cataract Refract Surg 34 1990 1991 10.1016/j.jcrs.2008.05.059 19006750
21. P.K. Kutty T.S. Forster C. Wood-Koob, et al. 2008 Multistate outbreak of toxic anterior segment syndrome, 2005 J Cataract Refract Surg 34 585 590 10.1016/j.jcrs.2007.11.037 18361979
22. N. Mamalis H.F. Edelhauser D.G. Dawson, et al. 2006 Toxic anterior segment syndrome J Cataract Refract Surg 32 324 333 10.1016/j.jcrs.2006.01.065 16565012
23. M. Sato T. Oshika 2008 2007 Survey of Japanese Society of Cataract and Refractive Surgery IOL/RS (Jpn Soc IOL & Refract Surg) 22 351 370
24. Y. Tsuchiya S. Kobayakawa A. Tsuji T. Tochikubo 2008 Preventive effect against postcataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics Curr Eye Res 33 868 875 1:CAS:528:DC%2BD1cXht1CqsLfE 10.1080/02713680802382971 18853321
25. T. Oshika T. Nagata Y. Ishii 1998 Adhesion of lens capsule to intraocular lenses of polymethylmethacrylate, silicone, and acrylic foldable materials: an experimental study Br J Ophthalmol 82 549 553 1:STN:280:DyaK1cznvVKrtA%3D%3D 10.1136/bjo.82.5.549 9713064
26. T. Oshika H. Hatano Y. Kuwayama, et al. 2007 Incidence of endophthalmitis after cataract surgery in Japan Acta Ophthalmol Scand 85 848 851 10.1111/j.1600-0420.2007.00932.x 17459028
27. L.R. Nelson D.O. Hodge W.M. Bourne 2000 In vitro comparison of Chen medium and Optisol-GS medium for human corneal storage Cornea 19 782 787 1:STN:280:DC%2BD3M7jsF2rsQ%3D%3D 10.1097/00003226-200011000-00005 11095050
28. H. Gao M.E. Pennesi X. Qiao, et al. 2006 Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models Invest Ophthalmol Vis Sci 47 1606 1611 10.1167/iovs.05-0702 16565399